ArticleCureus2024
Anti-Ro-Positive Dermatomyositis Presenting as a Clinical Mimic of Guillain-Barré Syndrome: A Case Report.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatomyositis is a multi-system, connective tissue immune-mediated inflammatory condition characterised by myositis and distinct skin manifestations, with a higher prevalence in women. Symptoms typically appear in adulthood, though a juvenile form exists. Early signs may include Gottron's papules and heliotrope rash, with proximal muscle weakness as the second most common initial symptom. This report discusses a case of a 55-year-old woman whose presentation initially resembled acute demyelinating polyneuropathy (ADP), beginning with an eight-week history of dry cough and a five-day history of diarrhoea for four weeks followed by muscle weakness and no skin signs. The patient, who had delayed medical attention, presented with significant proximal muscle weakness and absent reflexes, resulting in a debilitating reduction in her baseline mobility. Initial investigations that were conducted included an elevated creatinine kinase (CK) level and reduced forced vital capacity (FVC). Her cerebrospinal fluid (CSF) analysis showed elevated proteins. She was admitted to the intensive care unit due to a declining FVC, and receiving intravenous immunoglobulin (IVIG), which resulted in some improvement. Over time, she developed skin manifestations and responded to treatment with mycophenolate mofetil (MMF) and corticosteroids.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.